Company / Free Cash Flow per Share
Monte Rosa Therapeutics, Inc. Free Cash Flow per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.51
FY2024
5-year range
-$17.43 / $0.51
FY2020-FY2024
Trend
+142.1%
vs FY2023
Sector context
#58 of 192
Health Care
What the data says
At $0.51, Monte Rosa Therapeutics, Inc.'s free cash flow per share ranks #58 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $-17.43 in FY2020 to $0.51 in FY2024.
Based on SEC 10-K filings.
0.51 in FY2024.
Improved from $-2.23 to $0.51 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#58 of 192 in Health CareTop 30% of 192This company $0.51 Sector average -$19.84
▼
+102.6% above sector average
Key checks
Key Insights
- Monte Rosa Therapeutics, Inc.'s free cash flow per share has grown for 4 consecutive years.
- In FY2024, free cash flow per share increased 142.1% year-over-year.
- Ranks #58 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.51 | +142.1% |
| FY2023 | -$1.22 | +45.2% |
| FY2022 | -$2.23 | +19.3% |
| FY2021 | -$2.76 | +84.1% |
| FY2020 | -$17.43 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026